Today, Tuesday 19th September, details were released of a £172m investment into Plymouth based firm Becton Dickinson (BD). The Prime Minister is presently on a tour of North America and having visited Canada yesterday, has today arrived in New York to meet with business leaders regarding post Brexit business and investment.
BD, a global medical technology company, have a plant based in the north of Plymouth and manufacture a broad range blood collection products. At present, the facility employs 720 associates.
With an already large footprint in Plymouth, the £172m investment announced is likely to boost the headcount by 200 taking the total number up towards 1,000 people. This investment, which will also provide a hefty added boost to the local economy, comes following news that the UK has leapfrogged France into 8th place in the list of the top global manufacturers.
Johnny Mercer MP, whose constituency covers where BD is based, had this to say:
“I visited BD just before the General Election earlier this year and was excited to hear of their plans for expansion.
“Fortunately, I had brought the Foreign Secretary, Boris Johnson, who was delighted to talk about the UKs role in the world post-Brexit and the trading aims the country is hoping to achieve.
“It’s always a pleasure to talk about expanding companies and increases in highly-skilled and better paid employees. However, on this occasion, I really think it is a solid vote of support for Plymouth and the UK’s role in the world post-Brexit.
“BD are one of a number of top companies I’m lucky enough to represent and to hear of the £172m commitment to investing their future in Plymouth should be welcomed warmly by all. Plymouth is a great city with great opportunities; we shouldn’t be afraid to shout it about.”